Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00801476
Other study ID # MRI REB 07-458
Secondary ID
Status Recruiting
Phase N/A
First received December 2, 2008
Last updated November 17, 2009
Start date April 2008
Est. completion date May 2010

Study information

Verified date November 2009
Source McMaster University
Contact Shelley A Chambers, MA
Phone 905-387-9711
Email shelley.chambers@jcc.hhsc.ca
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

Young women with breast cancer have an increased breast tissue density and conventional imaging tests such as mammography and breast ultrasound are less sensitive and specific for detecting breast cancer than in older breast cancer patients. Breast MRI is an emerging tool that has been proven to improve the ability to identify breast cancers by determining the extent of disease and also detect multifocal, multicentric and bilateral breast cancers. To date, the role of pre-operative breast MRI is not clearly defined. The investigators are proposing a study to evaluate the impact of preoperative breast MRI on surgical decision-making in breast cancer patients <= 50 years. This may lead to improved characterization of breast cancers in these younger patients that may ultimately result in lower local recurrence rates in the future. The additional information attained through the breast MRI may also guide the use of radiation, chemotherapy and/or hormonal therapy in these patients.


Description:

Inclusion Criteria:

- female aged ≤ 50

- histologically proven invasive breast cancer

Exclusion Criteria:

- Is not considered a surgical candidate

- Has had prior breast cancer surgery or an excisional biopsy of the newly diagnosed lesion

- Has a contraindication to undergoing breast MRI

- Has inflammatory breast cancer according to the standard clinical definition

- Has locally advanced breast cancer according to the standard clinical definition

- Patient is pregnant

- Has a psychiatric or addictive disorder that would preclude obtaining informed consent or adherence to the protocol


Recruitment information / eligibility

Status Recruiting
Enrollment 44
Est. completion date May 2010
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender Female
Age group N/A to 50 Years
Eligibility Inclusion Criteria:

- Female aged <= 50 years

- Histological proof of invasive breast cancer via fine needle aspiration or core needle biopsy

- Premenopausal

Exclusion Criteria:

- Patient not considered an appropriate surgical candidate; i.e., patient is not well enough to have breast cancer surgery

- Patient has had prior breast cancer surgery or an excisional biopsy of the newly diagnosed cancer

- Patient has a contraindication to undergoing breast MRI (i.e., pacemaker, neurodefibrillator, metallic foreign bodies, etc.)

- Patient has inflammatory breast cancer according to the standard clinical definition. This is a type of breast cancer in which there is evidence of erythema and/or edema. The skin of the breast may also have changes of peau d'orange.

- Patient has locally advanced breast cancer according to the standard clinical definition.

- Patient is pregnant

- Patient has a psychiatric or addictive disorder that would preclude them from obtaining informed consent.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Procedure:
Pre-operative bilateral breast MRI
After the standard mammogram and ultrasound testing, the surgeon is asked which surgical procedure they feel is appropriate for the patient. A bilateral breast MRI is then performed prior to surgery. The surgeon is again asked which surgery they feel is appropriate based on the new information provided by the MRI. The study is trying to see if this pre-operative breast MRI helps define the tumour leading to a better first surgical decision.

Locations

Country Name City State
Canada Juravinski Cancer Centre Hamilton Ontario
Canada St. Josephs' Healthcare Hamilton Ontario

Sponsors (1)

Lead Sponsor Collaborator
McMaster University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Does pre-operative magnetic resonance imaging (MRI) effect surgical management in young women with breast cancer 3 months No
Secondary Proportion of patients requiring a second surgery due to positive tumour margins. 3 months No
Secondary Incidence of multifocal or multicentric or bilateral breast cancer found on MRI After surgery No
Secondary The correlation between MRI tumour size and the pathologic tumour size after surgery. 3 months No
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2